Myonex, a global leader in clinical trial supply, has completed the acquisition of SaveWay Compounding Pharmacy in Newark, Del. The pharmacy will operate as SaveWay Compounding Pharmacy, a Myonex Company.
This acquisition enables broader patient access across the United States, supporting patients in accessing study medications and devices to support clinical trial sponsors’ study designs with Direct-to-Patient (DTP) and Home Healthcare Provider (HHP) services.
Myonex is a global leader in clinical trial supply solutions, providing customized solutions for central and local drug sourcing, packaging, labeling, and the delivery of ancillary supplies and equipment to support the specific needs and complexities of each trial.
https://www.myonex.com/
